Spikevax bivalent Original/Omicron BA.1, pre-filled syringe - Labelling deviation
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Spikevax (previously COVID-19 Vaccine Moderna)
|
| Active substance |
CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2)
|
| Therapeutic area (MeSH) |
COVID-19 virus infection
|
| Regulatory outcome |
Variation
|
| DHPC type |
Adverse event
|
| Human ATC code |
J07BX03
|